Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Sep-Oct;26(5):578-84.
doi: 10.1007/s00246-005-0801-2.

Angiogenesis in fatal acute Kawasaki disease coronary artery and myocardium

Affiliations

Angiogenesis in fatal acute Kawasaki disease coronary artery and myocardium

A F Freeman et al. Pediatr Cardiol. 2005 Sep-Oct.

Abstract

Angiogenesis has been shown to be dysregulated in coronary artery (CA) aneurysms in the chronic phase of Kawasaki disease (KD). Neovascularization may occur in inflammatory-related vascular diseases because many angiogenesis mediators are secreted by inflammatory cells. We hypothesized that inflammation of the acute KD CA aneurysm could lead to dysregulation of angiogenesis mediators and subsequent neovascularization. To investigate this hypothesis, acute fatal KD cardiac tissues were immunostained for angiogenic inducers and inhibitors. Microvessel density was determined and the degree of inflammation assessed. Marked inflammation and angiogenesis were found in acute KD CA aneurysms and myocardium, with the highest microvessel density seen in patients who died 2-3 weeks after onset of the disease. Expression of proangiogenic proteins was higher than expression of inhibitors in KD CA aneurysms and myocardium. Angiogenesis mediators were localized to inflammatory cells in the myointima, adventitia, and myocardium. We conclude that significant neovascularization occurs in acute KD CA aneurysms and myocardium much sooner after onset of the disease than has been previously reported, that multiple angiogenesis factors are involved, and that dysregulation of angiogenesis likely contributes to KD vasculopathy.

PubMed Disclaimer

References

    1. J Immunol. 1994 Nov 1;153(9):4219-29 - PubMed
    1. Int Rev Cytol. 1995;159:113-60 - PubMed
    1. Circulation. 2000 Jun 27;101(25):2935-41 - PubMed
    1. J Immunol. 1994 Nov 15;153(10):4488-95 - PubMed
    1. Pediatr Res. 1998 Oct;44(4):596-9 - PubMed

Publication types

MeSH terms

LinkOut - more resources